When reaching out to investors for funding, you might wonder how some teams have succeeded in those initial conversations, while others haven't. Aside from describing the product and highlighting how it can help patients and medical providers, how can you showcase your startup to let investors know that your company has the key advantages that will set it apart?
BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, is hosting a panel "Navigating The Current Climate: How To Be Attractive To Investors with Holley Edyvane, Principal & Entrepreneur-in-Residence with Miramar Global". The panel will feature Francesca Barone, M.D., Ph.D., CSO with Candel Therapeutics, Stuart Chaffee, Ph.D., Entrepreneur-in-Residence with Atlas Venture, and Dave Greenwald, Ph.D., Vice President, Business Development at Deerfield Management.
The panelists will pay special attention to these key areas:
- Leadership team
- Differentiated science
- Data validation
The speakers will also offer tips on sources for gap funding. There will be ample time available for Q&A.
This event will be hybrid with limited in-person capacity at BioVenture eLab (1157 York Ave). Others are encouraged to participate via Zoom.